Skip to main content
. 2021 Oct 21;30(6):2635–2642. doi: 10.1044/2021_AJSLP-21-00058

Table 2.

Clinical findings for subgroups of PPA and PPAOS (M ± SD).

Speech/language assessment lvPPA svPPA nfPPA/AOS PPAOS
Western Aphasia Battery
 Aphasia Quotient (/100) 78.15 ± 14.8 83.97 ± 15.1 83.91 ± 11.9 97.31 ± 1.9
 Spontaneous Speech (/20) 15.68 ± 3.0 17.46 ± 2.5 15.50 ± 2.6 19.50 ± 0.5
 AV Comprehension (/10) 8.83 ± 1.1 8.95 ± 1.7 9.47 ± 0.6 9.93 ± 0.1
 Repetition (/10) 7.43 ± 1.7 9.06 ± 1.0 8.06 ± 2.4 9.65 ± 0.3
 Naming (/10) 7.17 ± 2.2 6.50 ± 2.8 8.61 ± 1.2 9.61 ± 0.3
 Animal (category) Fluency 9.17 ± 5.3 8.93 ± 5.1 11.38. ± 4.1 16.80 ± 3.7
Action Fluency 8.79 ± 4.6 11.80 ± 6.6 7.79 ± 4.2 13.37 ± 4.8
Letter Fluency 5.63 ± 3.8 7.26 ± 3.9 5.05 ± 2.7 7.96 ± 3.6
Boston Naming Test (/15) 6.86 ± 4.6 3.60 ± 3.6 12.47 ± 2.7 14.16 ± 0.9
ASRS 2.37 ± 1.8 0.13 ± 0.3 19.59 ± 11.6 19.13 ± 8.0

Note. lvPPA =logopenic; svPPA = semantic; nfPPA = nonfluent/agrammatic with or without apraxia of speech; AOS = apraxia of speech; PPAOS = primary progressive apraxia of speech; ASRS = Apraxia of Speech Rating Scale.